Monday's Prospects: Round 2

Of the 11 symbols that made it past my first round of analysis, one has survived second round: SLXP -- the drug development company Salix Pharmaceuticals. (See "Monday's Prospects" for a complete list of first-round survivors.)

Two failed confirmation, and the others faltered based on their charts being insufficiently trending to match the signal or because they lacked current momentum in the direction of the signal.

I shall post an analysis of SLXP prior to the closing bell today.

-- Tim Bovee, Portland, Oregon, June 23, 2014

References

My shorter-term trading rules can be read here. My longer-term trading rules can be read here. And the classic Turtle Trading rules on which my rules are based can be read here.

Disclaimer

Tim Bovee, Private Trader tracks the analysis and trades of a private trader for his own accounts. Nothing in this blog constitutes a recommendation to buy or sell stocks, options or any other financial instrument. The only purpose of this blog is to provide education and entertainment.

No trader is ever 100 percent successful in his or her trades. Trading in the stock and option markets is risky and uncertain. Each trader must make trading decisions for his or her own account, and take responsibility for the consequences.

License



All content on Tim Bovee, Private Trader by Timothy K. Bovee is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Based on a work at www.timbovee.com.